The Freudenberg Group recently stated in Shanghai that it will continue to increase investment in China and spend 150 million yuan to expand the Shanghai R&D center that is officially put into use this year. Biological Virgin Pulp Making System
The lack of paper
making raw materials is a common problem, the use of seasonal growth plants or
wild trees etc for the paper pulp is an effective solution.However, using this
material pulping will produce a lot of black liquor containing inorganic
compounds, how can get more fiber pulp, low investment to processing black
liquor which can let it reach the water
recycling or reach the discharge standard of environmental protection, it has
been a worldwide problem all the time.
Pulp Making Machine,Virgin Pulp Making Machine,Biological Virgin Pulp Making Machine,Biological Virgin Pulp Making System Dandong Tianshin Automatization Technology Co.,Ltd , https://www.ctpmmachine.com
In addition, Freudenberg will develop and put into operation advanced components for the Chinese electric vehicle market, including seals, battery separator materials, fuel cell humidifier modules, and hollow fiber membranes.
Freudenberg is a German company that focuses on auto parts business. It is mainly engaged in automotive sealing and shock control technology, automotive non-woven fabrics, filters, lubricants and modern household products. The business covers 58 countries around the world. , annual sales of more than 54 billion yuan. The Chinese market has always maintained an important position in the Freudenberg Group's global strategy. In the third quarter of 2012, Freudenberg's sales in China increased by nearly 10% from the same period last year to 2.98 billion yuan. In the coming years, Freudenberg's lubrication business, vibration reduction system business, and new energy vehicle business will all increase investment in China and expand production. Freudenberg said that it will also diversify its business in China, with a focus on investment in medical technology, etc. It will also adopt a "buy and build strategy" to ensure the growth of corporate profits. 